2019年中国创伤性休克创新急救复苏技术临床应用专家共识
该共识由中国研究型医院学会卫生应急委员会、心肺复苏专业委员会及河南省医院协会心肺复苏专业委员会共同制定,针对院前输血和血制品无法使用的创伤性休克急救场景,提出高渗凝胶复合液可小剂量治疗创伤性休克并稳定血压,可替代全血及其他血制品,提高转运至医院的安全性并为救命手术提供机会。同时,腹部提压心肺复苏解决了胸外伤后心脏骤停无法进行传统胸外按压患者的治疗难题,大幅提高院前治疗成功率。共识汇总了国内外已发表的创伤性休克与创伤性心脏骤停科学证据,基于中国国情提出创新急救复苏技术的临床应用专家共识。
要点
- 高渗凝胶复合液可小剂量治疗创伤性休克,稳定血压效果好,可替代全血及其他血制品,提高转运安全性并为救命手术提供机会。
- 腹部提压心肺复苏可解决胸外伤后心脏骤停患者无法进行传统胸外按压的难题,大幅提高院前治疗成功率。
- 共识针对院前输血和血制品无法使用的创伤性休克急救场景,解决容量复苏凝胶配比与比例问题。
- 共识基于中国国情,采用「产学研用」结合模式研发并推广腹部提压心肺复苏。
- 共识汇总了国内外已发表的创伤性休克与创伤性心脏骤停科学证据,提出临床应用专家共识。
适用人群与场景
- 创伤性休克患者,尤其是院前输血和血制品无法使用的急救场景。
- 胸外伤后心脏骤停且无法进行传统胸外按压的患者。
处置流程与药物剂量
- 高渗凝胶复合液可小剂量用于创伤性休克,稳定血压效果好,可替代全血及其他血制品,提高转运至医院的安全性,为救命手术提供机会。
- 腹部提压心肺复苏用于胸外伤后心脏骤停无法进行传统胸外按压的患者。
研究设计与关键结果
- 共识由中国研究型医院学会卫生应急委员会、心肺复苏专业委员会及河南省医院协会心肺复苏专业委员会共同制定,汇总了国内外已发表的创伤性休克与创伤性心脏骤停科学证据。
证据类型、等级与局限
- 证据类型:专家共识。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在院前输血和血制品无法使用的创伤性休克急救场景,高渗凝胶复合液可小剂量使用以稳定血压并替代全血及其他血制品。
- 对胸外伤后心脏骤停无法进行传统胸外按压的患者,可采用腹部提压心肺复苏。
指南或共识出处
- 2019年中国创伤性休克创新急救复苏技术临床应用专家共识,中国研究型医院学会卫生应急委员会、心肺复苏专业委员会、河南省医院协会心肺复苏专业委员会。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
To promote the clinical treatment technical training and popularization of traumatic shock and cardiac arrest, Health Emergency Committee of Chinese Research Hospital Association, Cardiopulmonary Resuscitation Specialized Committee of Chinese Research Hospital Association, Cardiopulmonary Resuscitation Specialized Committee of Henan Hospital Association jointly established "Chinese expert consensus on the clinical application of innovative first-aid resuscitation technology for traumatic shock in 2019". This consensus has solved the problem of volume resuscitated gel mix and ratio in the emergency situation of pre-hospital transfusion and blood products unable to be used in traumatic shock. Hypertonic gel compound liquid can treat traumatic shock with small dosage and good effect of stabilizing blood pressure, which can replace whole blood and other blood products, improve the safety of transport to hospital, and provide an opportunity for life-saving surgery. At the same time, abdominal lifting and compression cardiopulmonary resuscitation (CPR) has solved the difficulty of treating patients with post-traumatic cardiac arrest who cannot perform traditional chest compressive CPR, and greatly improved the success rate of pre-hospital treatment for patients with traumatic shock. In view of the actual demand of emergency medical treatment in China and the contraband of chest CPR for chest trauma, the combination of "administration, production, study, research and application" was adopted, and the abdominal lifting and compression CPR was successfully developed and popularized. This expert consensus summarized the scientific evidence on traumatic shock and traumatic cardiac arrest published at home and abroad so far, and put forward the expert consensus on the clinical application of innovative first-aid resuscitation technology for traumatic shock based on Chinese national conditions. This consensus incorporated the wisdom and philosophy of Chinese and foreign scholars in the training of traumatic shock and CPR, and would certainly make the training of traumatic shock and cardiac arrest in China entering a new stage with strong pertinence, quick onset, few side effects and high treatment rate.
参考来源
- Health Emergency Committee Of Chinese Research Hospital Association, Cardiopulmonary Resuscitation Specialized Committee Of Chinese Research Hospital Association, Cardiopulmonary Resuscitation Specialized Committee Of Henan Hospital Association, et al. [Chinese expert consensus on the clinical application of innovative first-aid resuscitation technology for traumatic shock in 2019]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 30914082. doi:10.3760/cma.j.issn.2095-4352.2019.03.001
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。